Abstract:Retinoic acid induced 1(RAI1) encodes a dosage-sensitive gene that when haploinsufficient results in Smith-Magenis syndrome (SMS) and when overexpressed results in Potocki-Lupski syndrome (PTLS). Phenotypic and molecular evidence illustrates that haploinsufficiency of RAI1disrupts circadian rhythm through the dysregulation of the master circadian regulator, circadian locomotor output cycles kaput(CLOCK), and other core circadian components, contributing to prominent sleep disturbances in SMS. However, the phenotypic and molecular characterization of sleep features in PTLS has not been elucidated. Using the Pittsburgh Sleep Quality Index (PSQI), caregivers of 15 school-aged children with PTLS reported difficulties in initiating sleep. Indeed, more than 70% of individuals manifested moderate to severe sleep latency, as defined by the PSQI. Moreover, these individuals manifested difficulties in sleep maintenance, with middle of the night and early morning awakenings. When assessing daytime sleepiness through the Epworth Sleepiness Scale, approximately 21% of the individuals manifested excessive daytime somnolence. This indicates that mild dyssomnia characterizes the majority of the sleep phenotype, with occasionally problematic daytime somnolence, a phenotype different than that expressed by individuals with SMS, where daytime sleepiness is a chronic problem. Gene expression analysis of the core circadian machinery in the hypothalamus of the PTLS mouse model (Rai1-Tg) found significant dysregulation of the transcriptional activators, ClockandArntl, and the transcriptional repressors,Per1-3andCry1/2, during both light and dark phases. These findings suggest a partial loss of circadian entrainment typically evoked by environmental photic cues. Examination of circadian clock gene expression in the Rai1-Tg mouse heart, liver, and kidney found unchanged expression ofClockand most of its downstream targets during both light and dark phases, suggesting an asynchronized circadian rhythm. Furthermore, examination of circadian gene expression in synchronized PTLS lymphoblasts revealed reduced transcripts of the Period (PER1-3) family and normal expression ofCRY1/2. The finding that central circadian gene expression was altered while many peripheral circadian components were intact suggests a tissue-specific circadian uncoupling of the circadian machinery due toRai1overexpression. Overall, our results demonstrate that overexpression of RAI1results in sleep deficiencies in individuals with PTLS due to a lack of properly regulated circadian machinery gene expression and highlight the importance of evaluating sleep concerns in individuals with PTLS.

Temporal Dissection of Rai1 Function Reveals Brain-Derived Neurotrophic Factor As a Potential Therapeutic Target for Smith-Magenis Syndrome.

Molecular and Neural Functions of Rai1, the Causal Gene for Smith-Magenis Syndrome

Early Adolescent Rai1 Reactivation Reverses Transcriptional and Social Interaction Deficits in a Mouse Model of Smith–Magenis Syndrome

Insulin-Like Growth Factor-1 Down-Regulates the Phosphorylation of FXYD1 and Rescues Behavioral Deficits in a Mouse Model of Rett Syndrome

Raldh1 Promotes Adiposity During Adolescence Independently of Retinal Signaling.

Loss of Rai1 enhances hippocampal excitability and epileptogenesis in mouse models of Smith-Magenis syndrome

RDH1 Suppresses Adiposity by Promoting Brown Adipose Adaptation to Fasting and Re-Feeding

Identification of a RAI1-associated disease network through integration of exome sequencing, transcriptomics, and 3D genomics

Comparative analyses of the Smith−Magenis syndrome protein RAI1 in mice and common marmoset monkeys

Retinoic acid-induced 1 gene haploinsufficiency alters lipid metabolism and causes autophagy defects in Smith-Magenis syndrome

Evidence for genetic regulation of mRNA expression of the dosage-sensitive gene retinoic acid induced-1 ( RAI1 ) in human brain

Rai1 Overexpression Promotes Altered Circadian Gene Expression and Dyssomnia in Potocki-Lupski Syndrome

Smith-Magenis Syndrome and Its Circadian Influence on Development, Behavior, and Obesity - Own Experience.

A survey of hypothalamic phenotypes identifies molecular and behavioral consequences of MYT1L haploinsufficiency in male and female mice.

Mechanistic Insights into Retinoic-Acid Treatment for Autism in the Improvement of Social Behavior: Evidence from a Multi Omics Study in Rats

Retinoic Acid Supplementation Rescues the Social Deficits in Fmr1 Knockout Mice

Mtorc1 is Involved in the Regulation of Bardet-Biedl Syndrome 1 (bbs1) Gene Expression

Bardet-Biedl syndrome proteins regulate intracellular signaling and neuronal function in patient-specific iPSC-derived neurons

Overlapping hearing and communication profiles for the deletion and the RAI1 variant form of Smith-Magenis Syndrome (SMS)

RASopathies influences on neuroanatomical variation in children.

Evidence for a Potential Common Gene Network of Smith-Magenis&nbsp;and Potocki-Lupski Syndromes,&nbsp;DAND (DEAF1-Associated Neurodevelopmental Disorder)&nbsp;and&nbsp;ZEB1-Associated Neurodevelopment Disorder